Project Grant HT94252510527
Award Date
7/15/25
Completion Date
7/14/29
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
The federal Project Grant award "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)" was provided by the Defense Health Agency under CFDA Program 12.420 - Military Medical Research and Development. The $1,479,970.00 award to The Ohio State University, with a performance period from July 15, 2025 to July 14, 2029, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on innovative...
The federal Project Grant award "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $1,465,907 award, made on Jul 15, 2025, supports advanced biomedical research at The Ohio State University (OSU) aimed at transforming healthcare for military service members, veterans, and the broader public. The project will focus on innovative research to address critical health...
The Department of Defense's Defense Health Agency awarded a $1,158,179.00 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to deliver a sustained therapeutic protein cocktail delivery system to prevent vision loss after ocular trauma. The project aims to develop innovative treatments for military service members and veterans by conducting basic, translational, and clinical research. As a sub-award under this grant, the...
The Defense Health Agency awarded a $512,751.00 Project Grant to The Ohio State University for the period from July 1, 2023 to June 30, 2026. The grant was provided under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public through innovative and impactful research, and to investigate medical solutions for the battlefield. The grant funds will...
The Department of Defense's Defense Health Agency awarded a $1,749,996.00 Project Grant to Vanderbilt University Medical Center (VUMC) on July 15, 2025 under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)," supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The funding will enable VUMC to conduct critical research...
The Ohio State University received a $248,237 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund a 3-year project from July 1, 2023 to June 30, 2026 to research and address traumatic brain injuries among law enforcement officers. No additional details about specific products or services to be delivered under this award were provided. The Military Medical Research and Development program supports basic,...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,181,250.00 to The Ohio State University to conduct research on the use of MIF inhibition and glucocorticoid therapeutics as a synergistic treatment to promote neuronal survival in traumatic retinal injury. The research aims to develop novel therapies for this type of injury, which is of particular relevance to military personnel. The...
The U.S. Defense Health Agency awarded a $320,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan. The grant, titled "IMPACT OF THE INTEGRATED STRESS RESPONSE ON VISUAL SYNAPTIC CIRCUITS IN MULTIPLE SCLEROSIS", will support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public. The research, to be conducted from September 1,...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $4,343,333 to Drexel University to support the "Development of PROM, Validation of Clinical Outcome Measures, Natural History, and Intervention for Mild Traumatic Brain Injury-Related Vision Disorders". The purpose of this 4-year award, effective from September 30, 2024 to September 29, 2028, is to develop and validate patient-reported...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...